Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos
The model's full reasoning — Q4 2017 call → NOWe need to determine if management identifies a specific, named dimension on which the company currently underperforms relative to industry peers, norms, or its own potential, and describes work already underway to close that gap, with management treating closing it as a meaningful source of improvement not dependent on market conditions. Let's scan the transcript for any such identification. Management discusses various metrics: revenue growth, EBITDA margins, NDRR, NPS, etc. They mention NDRR at 93%, which is in line with expectations, but they say "we're not satisfied, and we maintain our goal to consistently drive higher NDRR." That is a general aspiration, not a specific gap with a named benchmark. They don't say "we underperform peers by X%." They don't identify a specific deficiency. They mention professional services gross margin was 34% below target 40% due to newly acquired businesses, and they expect to bring those PSO teams into model over coming quarters. That is a specific gap: professional services gross margin below target. But is it a "named dimension on which the company currently underperforms relative to industry peers, norms, or its own demonstrated potential"? Yes, it's below their own target. And they describe work already underway? They say "we expect to bring these newly acquired PSO teams into model over the coming quarters." That is a plan, not necessarily already executing. They don't describe specific actions already taken. They just say they expect to bring them into model. That is more of a planned improvement, not concrete actions already executing. Also, is it a meaningful source of improvement? Possibly, but they don't quantify the impact. They don't say "this will add X basis points." They just mention it as a bit below target. Another potential: They mention AWS migration, which is a cost improvement, but that's not a gap; it's an operational improvement. They don't say they underperform on cost structure. They mention NPS scores increased and are in strong end of range, so no gap there. They mention organic growth is positive but low, but they don't frame it as a gap to close; they say they don't need it. Thus, the only specific gap mentioned is professional services gross margin below target, but the closing work is not described as already underway with a mechanism explained.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| SWK | Stanley Black & Decker, Inc. | Q1 2023 | 2023-05-04 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| ADNT | Adient plc | Q1 2018 | 2018-01-29 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| STKL | SunOpta Inc. | Q2 2017 | 2017-08-09 | C+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| PPG | PPG Industries, Inc. | Q1 2017 | 2017-04-20 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| SXT | Sensient Technologies Corporation | Q4 2016 | 2017-02-10 | A |
| BC | Brunswick Corporation | Q3 2016 | 2016-10-28 | B+ |
| SON | Sonoco Products Company | Q4 2015 | 2016-02-11 | B |
HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.